Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jun 7, 2023
Date Accepted: Aug 24, 2023

The final, peer-reviewed published version of this preprint can be found here:

Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation

Hinneburg J, Zacher S, Berger-Höger B, Berger-Thürmel K, Kratzer V, Steckelberg A, Lühnen J, on behalf of the TARGET group

Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation

JMIR Res Protoc 2023;12:e49731

DOI: 10.2196/49731

PMID: 37824180

PMCID: 10603554

Enhancing Trans-Sectoral Interdisciplinary Patient-Centred Care for Patients with Rare Cancers: Protocol for a Mixed Methods Process Evaluation

  • Jana Hinneburg; 
  • Sandro Zacher; 
  • Birte Berger-Höger; 
  • Karin Berger-Thürmel; 
  • Vanessa Kratzer; 
  • Anke Steckelberg; 
  • Julia Lühnen; 
  • on behalf of the TARGET group

ABSTRACT

Background:

The multi-component programme Trans-sectoral personalised care concept for patients with rare cancers (TARGET) aims to optimise trans-sectoral cooperation and coordination of care to enhance patient involvement and the medical care coordination of patients with rare cancers.

Objective:

This process evaluation will contribute to answering questions about intervention fidelity and the implementation of the trans-sectoral communication as well as to identifying and describing intended and non-intended effects of the intervention and will also contribute to exploring barriers and facilitators of the implementation.

Methods:

Data collection will include questionnaires, document analyses, semi-structured interviews and structured observations and will cover different aspects of process evaluation. Qualitative data will be analysed using qualitative content analysis according to Mayring. The data will finally be combined using between-methods triangulation.

Results:

The project received the funding decision on 1 March 2022. The intervention phase and recruitment for the process evaluation started on 1 March 2023. At the time of protocol submission in June 2023, eight doctors from haematology/oncology practices were enrolled. Data collection has already started.

Conclusions:

The TARGET project is a complex intervention that is to be implemented in an equally complex healthcare context. The process evaluation will help to understand the influence of contextual factors and to assess the mechanisms of change. Clinical Trial: Main trial: ISRCTN registry identifier: ISRCTN16441179, registered October 10, 2022 (https://doi.org/10.1186/ISRCTN16441179)


 Citation

Please cite as:

Hinneburg J, Zacher S, Berger-Höger B, Berger-Thürmel K, Kratzer V, Steckelberg A, Lühnen J, on behalf of the TARGET group

Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation

JMIR Res Protoc 2023;12:e49731

DOI: 10.2196/49731

PMID: 37824180

PMCID: 10603554

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.